Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach

Acute myeloid leukemia (AML) is a disease, which mainly affects the elderly population. Unfortunately, the prognosis of patients aged >65 years is dismal, with 1-year overall survival approaching 10% with conventional therapies. The hypothesis of harnessing the immune system against cancer, inclu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Isidori, Alessandro, Loscocco, Federica, Ciciarello, Marilena, Corradi, Giulia, Lecciso, Mariangela, Ocadlikova, Darina, Parisi, Sarah, Salvestrini, Valentina, Amadori, Sergio, Visani, Giuseppe, Curti, Antonio
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2018
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071222/
https://ncbi.nlm.nih.gov/pubmed/29932105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10070211
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki